About Syapse
Syapse is a company based in San Francisco (United States) founded in 2008 by Tony Loeser was acquired by N-Power Medicine in January 2025. Syapse has raised $221.1 million across 8 funding rounds from investors including Medidata, Intermountain Healthcare and General Electric. The company has 209 employees as of December 31, 2022. Syapse operates in a competitive market with competitors including BostonGene, VieCure, Melatech, Myka Labs and Kuveda, among others.
- Headquarter San Francisco, United States
- Employees 209 as on 31 Dec, 2022
- Founders Tony Loeser
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Syapse, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$221.1 M (USD)
in 8 rounds
-
Latest Funding Round
$35 M (USD), Series E
Jul 07, 2022
-
Investors
Medidata
& 15 more
-
Employee Count
209
as on Dec 31, 2022
-
Acquired by
N-Power Medicine
(Jan 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Syapse
Unlock access to complete
Unlock access to complete
Funding Insights of Syapse
Syapse has successfully raised a total of $221.1M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $35 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Syapse
Syapse has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Medidata, Intermountain Healthcare and General Electric.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified debt funding is provided for growth capital opportunities.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital is focused on the life science sector.
|
Locked | Locked | Locked |
Investor details for Syapse
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Syapse
Investment portfolio details for Syapse
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Syapse
Detailed financials for Syapse
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Syapse Comparisons
Peer comparison for Syapse
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Syapse
Syapse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BostonGene, VieCure, Melatech, Myka Labs and Kuveda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cloud-based information and analytics platform to treat cancer
|
|
| Locked | Locked | Locked |
Oncology treatment plans are generated via an AI-based platform.
|
|
| Locked | Locked | Locked |
AI-based patient treatment management tool for providers
|
|
| Locked | Locked | Locked |
AI-based integrated solutions for interventional oncology procedures are provided.
|
|
| Locked | Locked | Locked |
SaaS tools for analyzing cancer patients' molecular profiles are provided.
|
Detailed competitors of Syapse
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Syapse
Complete news archive for Syapse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syapse
Syapse was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Syapse is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ken Tarkoff is the current CEO of Syapse.
Syapse is a funded company, having raised a total of $221.1M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Syapse is 209.
Syapse was founded in 2008 in San Francisco, United States, within the healthcare technology sector. A platform is provided by the company to enable molecular profiling and analysis of complex genomic data from cancer patients. Operations focus on precision medicine solutions that support clinical decision-making. Services are extended to healthcare providers and researchers across the United States, emphasizing data-driven oncology approaches.
Syapse's top competitors include BostonGene, VieCure and Melatech.
Syapse has 16 investors. Key investors include Medidata, Intermountain Healthcare, General Electric, Social Capital, and Revelation Partners.